Among the different DC subsets, using bone marrow chimera experiments, Diamond and collaborators have demonstrated that Ifnar1−/− CD8α+ DCs lose their capability to cross present tumor antigens and as a consequence, when regressor tumors are transplanted, the host is no longer able to immune reject them [9]. The gene discussed is CD8A; the disease is neoplasm.